Global (S)-Equol Market Growth 2026-2032
Description
The global (S)-Equol market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
(S)-Equol is a more potent phytoestrogen derived from the transformation of soy isoflavones by gut microbiota. It has a stronger affinity for estrogen receptors and possesses various potential biological activities, including antioxidant effects, immune modulation, alleviation of menopausal symptoms, and benefits for bone and cardiovascular health. It is commonly used in health supplements, cosmetics, and pharmaceuticals.
The core raw material is daidzein, extracted from soybeans, and the process also involves the selection and breeding of special microorganisms (such as lactic acid bacteria and bifidobacteria). Downstream applications are highly concentrated in the health consumer sector, mainly covering dietary supplements for menopausal health, cosmeceutical products focused on skin anti-aging, and pharmaceutical research and development.
Global sales in 2025 are projected to be approximately 900 kilograms, with an average market price of around $6,000 per kilogram. Industry gross profit margins are expected to be in the range of 15%–30%.
(S)-Equol is considered a substance with the potential to redefine the standards of women's health supplements, particularly due to its advantages in regulating hormonal balance and managing menopausal symptoms, which are gradually being recognized by consumers and supported by some scientific evidence. Its naturally derived hormone-like effects make it more appealing in the health supplement market than traditional synthetic hormone replacement therapies.
The industry's driving factors stem primarily from consumers' increasing preference for natural, functional health products. The global nutraceutical and natural products market is already on an upward trend, with hormone balance and women's health being among the fastest-growing segments. (S)-Equol, as a metabolite of soy isoflavones, fits this trend due to its specific natural and active characteristics, which has driven manufacturers and brands to incorporate it into nutritional supplements, functional foods, and pharmaceutical formulations.
LP Information, Inc. (LPI) ' newest research report, the “(S)-Equol Industry Forecast” looks at past sales and reviews total world (S)-Equol sales in 2025, providing a comprehensive analysis by region and market sector of projected (S)-Equol sales for 2026 through 2032. With (S)-Equol sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world (S)-Equol industry.
This Insight Report provides a comprehensive analysis of the global (S)-Equol landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on (S)-Equol portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global (S)-Equol market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for (S)-Equol and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global (S)-Equol.
This report presents a comprehensive overview, market shares, and growth opportunities of (S)-Equol market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Purity≥99%
Purity<99%
Segmentation by Process:
Chemical Synthesis Method
Biological Fermentation Method
Segmentation by Sales Channels:
Direct Sales
Distribution
Segmentation by Application:
Pharmaceuticals
Food and Health Products
Skincare Products
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Otsuka Pharmaceutical
Daicel Corporation
Bonerge Lifescience
Anthem Biosciences
Shanghai EGT Synbio
Key Questions Addressed in this Report
What is the 10-year outlook for the global (S)-Equol market?
What factors are driving (S)-Equol market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do (S)-Equol market opportunities vary by end market size?
How does (S)-Equol break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
(S)-Equol is a more potent phytoestrogen derived from the transformation of soy isoflavones by gut microbiota. It has a stronger affinity for estrogen receptors and possesses various potential biological activities, including antioxidant effects, immune modulation, alleviation of menopausal symptoms, and benefits for bone and cardiovascular health. It is commonly used in health supplements, cosmetics, and pharmaceuticals.
The core raw material is daidzein, extracted from soybeans, and the process also involves the selection and breeding of special microorganisms (such as lactic acid bacteria and bifidobacteria). Downstream applications are highly concentrated in the health consumer sector, mainly covering dietary supplements for menopausal health, cosmeceutical products focused on skin anti-aging, and pharmaceutical research and development.
Global sales in 2025 are projected to be approximately 900 kilograms, with an average market price of around $6,000 per kilogram. Industry gross profit margins are expected to be in the range of 15%–30%.
(S)-Equol is considered a substance with the potential to redefine the standards of women's health supplements, particularly due to its advantages in regulating hormonal balance and managing menopausal symptoms, which are gradually being recognized by consumers and supported by some scientific evidence. Its naturally derived hormone-like effects make it more appealing in the health supplement market than traditional synthetic hormone replacement therapies.
The industry's driving factors stem primarily from consumers' increasing preference for natural, functional health products. The global nutraceutical and natural products market is already on an upward trend, with hormone balance and women's health being among the fastest-growing segments. (S)-Equol, as a metabolite of soy isoflavones, fits this trend due to its specific natural and active characteristics, which has driven manufacturers and brands to incorporate it into nutritional supplements, functional foods, and pharmaceutical formulations.
LP Information, Inc. (LPI) ' newest research report, the “(S)-Equol Industry Forecast” looks at past sales and reviews total world (S)-Equol sales in 2025, providing a comprehensive analysis by region and market sector of projected (S)-Equol sales for 2026 through 2032. With (S)-Equol sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world (S)-Equol industry.
This Insight Report provides a comprehensive analysis of the global (S)-Equol landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on (S)-Equol portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global (S)-Equol market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for (S)-Equol and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global (S)-Equol.
This report presents a comprehensive overview, market shares, and growth opportunities of (S)-Equol market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Purity≥99%
Purity<99%
Segmentation by Process:
Chemical Synthesis Method
Biological Fermentation Method
Segmentation by Sales Channels:
Direct Sales
Distribution
Segmentation by Application:
Pharmaceuticals
Food and Health Products
Skincare Products
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Otsuka Pharmaceutical
Daicel Corporation
Bonerge Lifescience
Anthem Biosciences
Shanghai EGT Synbio
Key Questions Addressed in this Report
What is the 10-year outlook for the global (S)-Equol market?
What factors are driving (S)-Equol market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do (S)-Equol market opportunities vary by end market size?
How does (S)-Equol break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
77 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for (S)-Equol by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for (S)-Equol by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
